IL10 and urinary bladder cancer: Additionally, IL-10 −1082A>G polymorphism was also significantly associated with the risk of bladder cancer in AA versus GG (P = 0.02, OR 2.00, 95% CI 1.13–3.55), AG versus GG (P = 0.01, OR 2.03, 95% CI 1.16–3.55), and GG versus AA+AG (P = 0.009, OR 0.49, 95% CI 0.28–0.84).